Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac IPO & Placement Research, China biotech

A/H Premium Weekly: Tigermed, Zoomlion, Flat Glass, Baiyunshan, Hepalink at 52w High

A/H Premium Weekly: Health Care A/H Premium at 52W High

A/H Premium Weekly: Consumer and Health Care Lowered A/H Premium

A/H Premium Weekly: Industrial Sector at 52 Week High

A/H Premium Weekly: Utility Led the Premium Increase

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Quantitative Analysis

<ul>
<li>We analyse the changes of A/H premium on 134 stocks over the last week. </li>
<li>Consumer Discretionary sector led the A/H increase which was due to Xinjiang Lachapelle and Zhejiang Shibao, while consumer staple saw the biggest A/H premium decline among sectors. </li>
<li>We highlight stocks at 52 week high of A/H premium: Angang Steel, Zoomlion and BBMG. </li>
</ul>


We analyse the changes of A/H premium on 134 stocks over the last week. 
Consumer Discretionary sector led the A/H increase which was due to Xinjiang Lachapelle and Zhejiang Shibao, while consumer staple saw the biggest A/H premium decline among sectors. 
We highlight stocks at 52 week high of A/H premium: Angang Steel, Zoomlion and BBMG. 


Chongqing Rural Commercial Bank (3618 HK)

China International Capital Corporation (3908 HK)

Beijing Jingcheng Machinery Electric (187 HK)

Shandong Xinhua Pharmaceutical Company (719 HK)

A/H Premium Weekly: Angang Steel, Zoomlion, BBMG at 52 Week High